Pink Sheet Pharma Intelligence published the attached article by Francesca Bruce on February 17, 2017. The article provides a helpful summary of the current pan-Canadian Pharmaceutical Alliance (pCPA) Biologics/Biosimilar Consultations. We thank Ms. Bruce for seeking our perspective on this topic and Pink Sheet for granting permission to post this article.
A copy of the article can be downloaded here.
To receive timely industry updates and insights please be sure to sign up for Market Access Signals, our free e-mail newsletter service.